GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Days Sales Outstanding

SBMFF (Sino Biopharmaceutical) Days Sales Outstanding : 63.54 (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical Days Sales Outstanding?

Sino Biopharmaceutical's average Accounts Receivable for the six months ended in Jun. 2024 was $762 Mil. Sino Biopharmaceutical's Revenue for the six months ended in Jun. 2024 was $2,188 Mil. Hence, Sino Biopharmaceutical's Days Sales Outstanding for the six months ended in Jun. 2024 was 63.54.

The historical rank and industry rank for Sino Biopharmaceutical's Days Sales Outstanding or its related term are showing as below:

SBMFF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.3   Med: 45.25   Max: 67.6
Current: 67.6

During the past 13 years, Sino Biopharmaceutical's highest Days Sales Outstanding was 67.60. The lowest was 32.30. And the median was 45.25.

SBMFF's Days Sales Outstanding is ranked better than
54.29% of 851 companies
in the Biotechnology industry
Industry Median: 73.17 vs SBMFF: 67.60

Sino Biopharmaceutical's Days Sales Outstanding declined from Jun. 2023 (69.84) to Jun. 2024 (63.54).


Sino Biopharmaceutical Days Sales Outstanding Historical Data

The historical data trend for Sino Biopharmaceutical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Days Sales Outstanding Chart

Sino Biopharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.20 37.13 51.24 52.87 55.76

Sino Biopharmaceutical Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.76 69.84 83.21 63.54 85.75

Competitive Comparison of Sino Biopharmaceutical's Days Sales Outstanding

For the Biotechnology subindustry, Sino Biopharmaceutical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biopharmaceutical's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Days Sales Outstanding falls into.


;
;

Sino Biopharmaceutical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sino Biopharmaceutical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (533.9 + 529.035) / 2 ) / 3669.282*365
=531.4675 / 3669.282*365
=52.87

Sino Biopharmaceutical's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding (Q: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (529.035 + 994.602) / 2 ) / 2188.154*365 / 2
=761.8185 / 2188.154*365 / 2
=63.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biopharmaceutical  (OTCPK:SBMFF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Sino Biopharmaceutical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biopharmaceutical Business Description

Traded in Other Exchanges
Address
1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2024, 41.8% of the firm's total revenue comes from its innovative product category, which includes innovative drugs and biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 37.2% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

Sino Biopharmaceutical Headlines

From GuruFocus

Matthews China Fund Comments on Sino Biopharmaceutical

By Sydnee Gatewood Sydnee Gatewood 01-28-2020

GuruFocus Value Idea Contest Sees 2 Winners!

By Holly LaFon Holly LaFon 07-12-2019

Sino Biopharmaceutical Ltd's Dividend Analysis

By GuruFocus Research 06-11-2024

Value Idea Contest: Sino Biopharmaceutical

By Matthew Sipos Matthew Sipos 01-10-2019

Matthews China Fund Comments on Sino Biopharmaceutical

By Vera Yuan Vera Yuan 10-20-2014